ESTS staging guidelines for non-small cell lung cancer: a good guide to best ever accuracy and high survival rate

Lung cancer causes most of the cancer-related deaths in men and women in the world (1). It is responsible for almost one-quarter (23.6%) of all cancer deaths in men and 13.8% in women. Most of the patients with non-small cell lung cancer (NSCLC) can be diagnosed at an extensive stage with metastasis so they can not receive surgical therapy according to the published evidence (2).